Skip to main content

Smith, McElroy, and gossip

George H. Smith is a well-known atheist and libertarian writer, born in Japan in 1949.
Smith is perhaps best known for Atheism: The Case Against God (1974) . I remember reading this long ago because it had a chapter combining and (unintelligently criticizing) two of the authors I most admire, Blaise Pascal and William James.

Smith has become part of a heated controversy in recent days that involves ideas about liberty and feminism, and quite personal accusations involving a thinker/writer who describes herself as working “within the individualist-anarchist tradition,” and a person with whom Smith once had an intimate and a professional relationship, Wendy McElroy.

McElroy, pictured here, has become very public in recent months as an opponent of the whole notion of a “rape culture” on campus, and the attendant notion that colleges as social micro-cosmos' have to ‘do something.’ Her advice to victims? “Rape is a criminal offense, go to the police.”  Pending the development of anarchistic alternatives to “the police,” presumably.

Her relationship with Smith has become rancorous due in part to intellectual-property disputes that arose out of the period of their collaboration. They apparently wrote a manuscript, together, on reasoning. After they separated, McElroy wrote a book called THE REASONABLE WOMAN, which Smith now claims was largely plagiarized from him. McElroy claims it was and is “an entirely separate work” from their earlier discarded manuscript.

On February 22, 2015, Sharon Presley, a psychologist who seems to have a close relationship with Smith, wrote unflatteringly about McElroy on a moderated website.  This inspired McElroy’s husband to reply in a letter the moderators of that site then deleted, but which re-appeared here. on Feb.22 . Wendy herself then expanded her husband’s stated grievances about the Presley/Smith attacks.

I haven’t found McElroy’s husband’s surname anywhere in this exchange. He just goes by Brad so far as I can tell.

Anyway, I have left the personal charges and counter-charges out of this brief description (plagiarism and IP issues are the very least of it). I’ll just say that it gets very nasty, that you can read more about it if you follow those links. 

Okay, it's low minded gossip even to mention it here, but I don't do a lot of that on this blog so I figured I could be forgiven one.


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…